Erasca

Erasca Receivables

Accounts Receivable of Erasca (ERAS) as of Nov 4, 2026.

Receivables

-USD

Last updated:

Accounts Receivable of Erasca is 2026 - USD. Accounts Receivable of Erasca was 2025 - USD. It decreases by % lower compared to the previous year.

The Erasca Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2019
0.00 USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
The Erasca Receivables history
YEARReceivablesYoY
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Erasca Stock analysis

What does Erasca do? Erasca Inc., based in San Diego, US, is a clinical-stage precision oncology company focused on developing therapies for RAS/MAPK pathway-driven cancers. The company operates with a pipeline of 12 programs, including five clinical-stage candidates such as naporafenib, an ATP-competitive pan-RAF inhibitor, and seven discovery-stage initiatives targeting key oncogenic drivers. With 103 employees, Erasca is listed on the stock market since July 15, 2021. Erasca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Erasca stock

On Eulerpool you can find the complete historical development of Accounts Receivable Erasca since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Erasca historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Erasca

All Key Metrics — Erasca